PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test sale cost 4400 AED
GP1BA Gene Bernard Soulier Syndrome Type A1 Genetic Test sale cost 4400 AED GP1BA Gene Bernard Soulier Syndrome Type A1 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
NR3C2 Gene Hypertension Early Onset Genetic Test sale cost 4400 AED NR3C2 Gene Hypertension Early Onset Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test” is a specialized diagnostic tool designed to assess the risk associated with carotid artery disease by examining the PPARG gene. The PPARG (Peroxisome Proliferator-Activated Receptor Gamma) gene plays a crucial role in the regulation of fatty acid storage and glucose metabolism, which are key factors in the development of atherosclerosis, leading to increased carotid intimal medial thickness (CIMT). An increased CIMT is a significant predictor of cardiovascular events, including stroke and heart attack.

This genetic test, available at DNA Labs UAE for a cost of 4400 AED, involves a non-invasive procedure that requires a simple blood sample from the patient. The analysis focuses on identifying specific mutations or variations in the PPARG gene that may contribute to the increased risk of developing thicker carotid artery walls, which can impede blood flow and lead to serious cardiovascular conditions. The test results can provide valuable information for both patients and healthcare providers, enabling them to understand genetic predispositions and potentially tailor prevention strategies or treatments to manage or mitigate the risk of carotid artery disease and its complications.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test

Welcome to DNA Labs UAE, where we offer the PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test. This test is designed to provide valuable insights into an individual’s genetic predisposition to develop increased CIMT and potentially guide personalized treatment or preventive strategies for cardiovascular disease.

Test Name: PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test

Components: DNA Labs UAE offers this comprehensive genetic test at a cost of 4400.0 AED.

Sample Condition: The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery: The test results will be delivered within 3 to 4 weeks.

Method: We utilize NGS Technology for this genetic test.

Test Type: The PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test falls under the category of Vascular Diseases.

Doctor: This test can be ordered by a General Physician.

Test Department: Our Genetics department handles this test.

Pre Test Information: It is important to provide the clinical history of the patient who is undergoing the PPARG Gene Carotid Intimal Medial Thickness Type 1 NGS Genetic DNA Test. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected by the PPARG Gene Carotid Intimal Medial Thickness Type 1 NGS Genetic DNA Test gene PPARG.

Test Details

The PPARG gene is responsible for encoding the peroxisome proliferator-activated receptor gamma, a nuclear receptor involved in regulating the expression of genes related to lipid and glucose metabolism. Carotid intimal medial thickness (CIMT) refers to the thickness of the innermost layers of the carotid artery, which serves as an indicator of atherosclerosis and cardiovascular disease risk.

Type 1 NGS (Next-Generation Sequencing) genetic testing is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes. In the context of PPARG and CIMT, a type 1 NGS genetic test involves sequencing the PPARG gene to identify any variations or mutations that may be associated with changes in CIMT and increased cardiovascular disease risk.

By identifying specific genetic variants in the PPARG gene, this type of genetic test can provide valuable insights into an individual’s genetic predisposition to develop increased CIMT. This information can potentially guide personalized treatment or preventive strategies for cardiovascular disease.

Test Name PPARG Gene Carotid intimal medial thickness type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Vascular Diseases
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PPARG Gene Carotid intimal medial thickness type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PPARG Gene Carotid intimal medial thickness type 1 NGS Genetic DNA Test gene PPARG
Test Details

The PPARG gene is responsible for encoding the peroxisome proliferator-activated receptor gamma, which is a nuclear receptor involved in regulating the expression of genes related to lipid and glucose metabolism. Carotid intimal medial thickness (CIMT) refers to the thickness of the innermost layers of the carotid artery, which can be an indicator of atherosclerosis and cardiovascular disease risk.

Type 1 NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput sequencing technology that can analyze multiple genes simultaneously. In the context of PPARG and CIMT, a type 1 NGS genetic test would involve sequencing the PPARG gene to identify any variations or mutations that may be associated with changes in CIMT and increased cardiovascular disease risk.

By identifying specific genetic variants in the PPARG gene, this type of genetic test can provide insights into an individual’s genetic predisposition to develop increased CIMT and potentially guide personalized treatment or preventive strategies for cardiovascular disease.

SKU: TEST-3517 Category:

Related products